Exosomes derived from cells have been found to mediate signal transduction between cells and to act as efficient carriers to deliver drugs and small RNA. Hepatocyte growth factor (HGF) is known to promote the growth of both cancer cells and vascular cells, and the HGF-cMET pathway is a potential clinical target. Here, we characterized the inhibitory effect of HGF siRNA on tumor growth and angiogenesis in gastric cancer. In addition, we showed that HGF siRNA packed in exo- -
effort is needed to explore the role of exosomes in the transport of siRNA. 9, 10 RNA interference has become a promising tool for clinical therapy, guiding sequence-specific endonucleolytic cleavage of mRNA and resulting in specific gene silencing. 11 However, there are major limitations of the use of siRNA as a therapeutic tool, including its degradation by extracellular nucleases and poor cellular uptake.
Although a number of vehicles, such as cationic liposomes, viral vectors and nanoparticles, have been used to transport siRNA, there are disadvantages of each method. 12, 13 Therefore, it remains a challenge to deliver interfering RNA to tumor cells in vivo.
Hepatocyte growth factor (HGF) was first discovered in mouse livers and is a multifunctional cytokine that has important roles in cell proliferation, survival, motility and morphogenesis. 14, 15 HGF has been found to be upregulated in various tumor tissues, and its upregulation is closely linked with tumor development. cMET, the receptor of HGF, is widely expressed in various types of epithelial, endothelial and hematopoietic progenitor cells. [16] [17] [18] The HGF-cMET axis is involved in several biological processes, such as embryogenesis, organogenesis, adult tissue regeneration and carcinogenesis, including both solid and hematological malignancies. 19 Thus, the HGF-cMET pathway has been considered as a novel target for cancer therapy.
20,21
The present study is designed to investigate whether cell-derived exosomes can be used as a delivery vehicle for siRNA and to evalu- 
| MATERIALS AND METHODS

| Human tissue
Human gastric cancer tissues and paired adjacent non-cancerous tissues were acquired from patients undergoing surgical procedures at the Tianjin Medical University Cancer Institute and Hospital (Tianjin, China). Both tumor tissues and non-cancerous tissues were confirmed histologically. The pathological type of each cancer was determined to be glandular carcinoma. Written consent (for both study participation and publication of identifying information/images) was provided by all patients, and the Ethics Committee of the Tianjin Medical University Cancer Institute and Hospital approved all aspects of this study. Tissue fragments were immediately frozen in liquid nitrogen at the time of surgery and stored at À80°C. All experiments were performed in accordance with relevant guidelines and regulations.
| Animals
Male nude mice (BALB/c-nu, 5-6 weeks) were housed in a pathogenfree animal facility with access to water and food ad libitum. All experimental procedures were performed in accordance with protocols approved by the Institutional Animal Care and Research Advisory Committee of the Tianjin Medical University Cancer Institute and Hospital.
| Cell culture
Human gastric cell line SGC-7901 and human embryo kidney epithelial cell line (HEK293T) were cultured in DMEM (Gibco, New York, NY, USA) supplemented with 10% FBS (Gibco); HUVEC were cultured in MCDB131 (Gibco) supplemented with 10% FBS, 10%
MVGS, 1% Glutamine and 1% HEPES. All cells were maintained in a humidified incubator at 37°C with 5% CO 2 .
| Cell transfection
Cells were seeded into a 10 cm or 6-well plate, and transfection was 
| Isolation exosomes from medium
Exosomes were isolated from cell culture medium by differential centrifugation, as previously published. 22, 23 After removing cells and other debris by centrifugation at 300 and 3000 g, the supernatants were centrifuged at 110 000 g for 70 minutes (all steps were performed at 4°C). Exosomes were collected from the resulting pellets and resuspended in PBS.
| Transmission electron microscopy
For conventional transmission electron microscopy (TEM), exosome pellets were placed in a droplet of 2.5% glutaraldehyde in PBS buffer at pH 7.2 and fixed overnight at 4°C. The samples were rinsed in PBS (3 times, 10 minutes each) and post-fixed in 1% osmium tetroxide for 60 minutes at room temperature. The samples were then embedded in 10% gelatin, fixed in glutaraldehyde at 4°C and cut into several blocks (smaller than 1 mm 3 ). The samples were dehydrated for 10 minutes per step in increasing concentrations of alcohol (30%, 50%, 70%, 90%, 95% and 100% 9 3). Next, pure alcohol was replaced with propylene oxide, and the specimens were infiltrated with increasing concentrations (25%, 50%, 75% and 100%) of Quetol-812 epoxy resin mixed with propylene oxide for a minimum of 3 hours per step. 
| Vascular ring formation of HUVEC cells
In vitro ring formation assays were performed with endothelial cells as previously described. 
| ELISA analysis
The release of VEGF from SGC7901 cells was examined using an ELISA kit (Thermo, EHVEGFACL, Carlsbad, CA, USA) according to the manufacturer's protocols. Briefly, 100 lL of each standard and sample was added into appropriate wells and agitated gently at room temperature.
| Exosome incubation with cells
Empty exosomes, or exosomes loaded with HGF siRNA or scramble RNA (100 lg exosomes per 10 6 cells), were incubated with SGC-7901 cells for 24 hours. The recipient cells were then collected for subsequent analysis.
| RNA isolation and quantitative RT-PCR
Total RNA was isolated from cultured cells and tissues using TRIzol Reagent (Invitrogen) according to the manufacturer's protocol.
Subsequently, 2 lL of total RNA was reverse-transcribed to cDNA (16°C for 15 minutes, 42°C for 60 minutes and 85°C for 5 minutes).
Gene-specific PCR products were measured using qRT-PCR with a SYBR Green PCR Kit (Takara, Dalian, China) on a CFX96 Real-time RT-PCR System. The relative expression levels of target genes were normalized to the control using the 2 ÀDCt method. To calculate the expression levels of target siRNA, a series of siRNA oligonucleotides at known concentrations in water were reverse-transcribed and amplified to generate a standard curve. Then, siRNA was quantified based on the standard curve. Roche Diagnostics, Mannheim, Germany) for 10 minutes at RT.
| Cell migration assay
The migratory capacity of the cells was tested using a Transwell Boyden chamber (6.5-mm, Costar) with polycarbonate membranes 
| Western blotting analysis
The expression of HGF was assessed by western blotting, and protein levels were normalized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Immunoblots were blocked with PBS containing 5% fat-free dried milk at room temperature for 1 hour and incubated at 4°C overnight with anti-HGF (1:1000; Santa Cruz) and anti-GAPDH (1:2000; Santa Cruz) antibodies.
| Immunohistochemistry
Tumors were fixed in 4% paraformaldehyde, embedded in paraffin, Mice were killed on the 23th day and the weights and diameters of their tumors were recorded.
| Statistical analyses
All data are representative of 5 or 6 independent experiments. Data are expressed as the means AE SE of at least 5 separate experiments.
Differences with P < .05 were considered statistically significant using Student's t-test. In this study, *, ** and *** indicate P < .05, P < .01 and P < .001, respectively.
3 | RESULTS
| Hepatocyte growth factor is upregulated in gastric cancer
The expression of HGF has been reported to be upregulated in various cancers and, thus, HGF is a potential serum marker for tumor diagnosis. [27] [28] [29] Here, we first checked HGF levels in both the tissues and sera of gastric cancer patients. The HGF protein was clearly increased in cancer tissues compared with adjacent tissues (Figure 1A,B) . We also quantified the levels of HGF mRNA by quantitative RT-PCR (RT-qPCR), and the results showed that HGF mRNA is upregulated in cancer tissues ( Figure 1C ). As expected, serum HGF was much higher in gastric cancer patients than in healthy subjects ( Figure 1D ). These data suggest that HGF acts as an oncogene in gastric cancer. 
| Packaging of hepatocyte growth factor siRNA in HEK293T-derived exosomes
We next sought to separate exosomes from other extracellular vesicles by differential centrifugation. We defined exosomes as approximately 30-100 nm vesicles as determined with TEM (Figure 3A,B) . The enrichment of exosome markers TSG101, CD9 and CD63 confirmed that we had successfully isolated exosomes (Figure 3C) . For exosome loading, HGF siRNA were transfected into HEK293T cells and then exosomes were isolated. As shown in Figure 3D , HEK293T-derived exosomes selectively packaged HGF siRNA. The concentration of HGF siRNA in these exosomes was calculated through qRT-PCR and the results clearly showed that HGF siRNA was effectively packaged into exosomes ( Figure 3E ).
The encapsulation efficiency was also calculated to prove the high efficiency of HGF siRNA packaged into exosomes ( Figure 3F ). In conclusion, we verified that exosomes are potential carriers of siRNA.
3.4 | siRNA against hepatocyte growth factor exosomes suppress hepatocyte growth factor/VEGF expression in SGC-7901 cells Figure 4C , we found that the recipient cells displayed red fluorescence, which confirmed that the exosomes had fused with recipient cells. Figure 4A ,B,D show that exosomes packaged with si.HGF-1 significantly decreased the protein and mRNA expression levels of HGF and VEGF, and this relationship was dose-dependent. Next, the release of VEGF from SGC-7901 cells was analyzed using an ELISA kit. We observed similar changes in HGF along with a range of inhibitory effects across siRNA treatments ( Figure 4E ). Therefore, exosomes can serve as carries to deliver HGF siRNA to inhibit HGF and VEGF expression. The preference for siRNA is related to their ease of synthesis, and the fact that they act in the cytoplasm rather than the nucleus, which facilitates their delivery. 32 Even if few molecules of siRNA are delivered intact into the cytosol, they are likely sufficient to trigger a sustained gene silencing effect. Therefore, to enhance the clinical use of siRNA, finding an appropriate carrier to deliver siRNA to target cells is urgent.
Exosomes are naturally secreted, nano-sized, lipid bilayer membrane-enclosed vesicles that can cross biological membranes/barriers and deliver their payloads to recipient cells with virus-like efficiency. 
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